DMAC vs NAUT
Comparison between DiaMedica Therapeutics Inc (DMAC, Company) and Nautilus Biotechnology Inc (NAUT, Company).
Both DMAC and NAUT are from the Healthcare sector.
5-Year PerformanceDMAC has outperformed NAUT, delivering a return of -8.8% compared to -26.5%
DMAC vs NAUT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DMAC vs NAUT - Historical Returns
Returns include dividend reinvestment.
DMAC vs NAUT - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | DMAC | NAUT |
|---|---|---|
| 2026 | -28.75% | +17.28% |
| 2025 | +44.46% | +15.38% |
| 2024 | +91.87% | -44.37% |
| 2023 | +91.89% | +76.92% |
| 2022 | -59.28% | -66.04% |
| 2021 | -62.85% | -52.91% |
| 2020 | +108.64% | N/A |
| 2019 | +50.15% | N/A |
| 2018 | -40.34% | N/A |
| 2017 | +127.69% | N/A |
| 2016 | +15.58% | N/A |
| 2015 | +90.00% | N/A |
| 2014 | -93.50% | N/A |
| 2013 | -33.49% | N/A |
| 2012 | -25.92% | N/A |
| 2011 | +64.60% | N/A |
| 2010 | +95.49% | N/A |
| 2009 | -58.86% | N/A |
| 2008 | -9.15% | N/A |
DMAC vs NAUT Drawdown Comparison
The maximum drawdown for DMAC was -98.16%, occurring on Dec 5, 2014. This drawdown has not yet recovered.
The maximum drawdown for NAUT was -94.19%, occurring on Sep 3, 2025. This drawdown has not yet recovered.
The current DMAC drawdown is -87.21%. The current NAUT drawdown is -79.64%.
| Rank | DMAC | NAUT |
|---|---|---|
| #1 | -98.16% Aug 7, 2012 - Dec 5, 2014 | -94.19% Jun 10, 2021 - Sep 3, 2025 |
| #2 | -73.05% Jan 4, 2008 - Jan 25, 2011 | N/A |
| #3 | -36.88% Mar 8, 2011 - Feb 27, 2012 | N/A |
| #4 | -25.49% Feb 28, 2012 - Jul 31, 2012 | N/A |
| #5 | -16.15% Jan 27, 2011 - Mar 8, 2011 | N/A |
Correlation
Correlation between DMAC and NAUT is -0.13 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks